Software - Application
Compare Stocks
4 / 10Stock Comparison
SURG vs NVDA vs AMD vs LQDT
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Specialty Retail
SURG vs NVDA vs AMD vs LQDT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Software - Application | Semiconductors | Semiconductors | Specialty Retail |
| Market Cap | $11M | $5.23T | $742.11B | $1.12B |
| Revenue (TTM) | $50M | $215.94B | $37.45B | $480M |
| Net Income (TTM) | $-42M | $120.07B | $4.99B | $30M |
| Gross Margin | -38.6% | 71.1% | 50.3% | 23.2% |
| Operating Margin | -78.8% | 60.4% | 11.7% | 8.4% |
| Forward P/E | — | 26.0x | 62.4x | 24.5x |
| Total Debt | $5M | $11.41B | $4.47B | $14M |
| Cash & Equiv. | $12M | $10.61B | $5.54B | $175M |
SURG vs NVDA vs AMD vs LQDT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| SurgePays, Inc. (SURG) | 100 | 3.6 | -96.4% |
| NVIDIA Corporation (NVDA) | 100 | 2423.6 | +2323.6% |
| Advanced Micro Devi… (AMD) | 100 | 846.1 | +746.1% |
| Liquidity Services,… (LQDT) | 100 | 633.8 | +533.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SURG vs NVDA vs AMD vs LQDT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SURG is the clearest fit if your priority is defensive.
- Beta 1.27, current ratio 2.95x
NVDA carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 65.5%, EPS growth 66.7%, 3Y rev CAGR 100.0%
- 243.2% 10Y total return vs AMD's 123.7%
- PEG 0.27 vs AMD's 12.08
- 65.5% revenue growth vs SURG's -55.6%
AMD is the clearest fit if your priority is momentum.
- +347.6% vs SURG's -80.0%
LQDT is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 1 yrs, beta 0.82
- Lower volatility, beta 0.82, Low D/E 6.9%, current ratio 1.38x
- Lower P/E (24.5x vs 62.4x)
- Beta 0.82 vs AMD's 2.52, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 65.5% revenue growth vs SURG's -55.6% | |
| Value | Lower P/E (24.5x vs 62.4x) | |
| Quality / Margins | 55.6% margin vs SURG's -83.4% | |
| Stability / Safety | Beta 0.82 vs AMD's 2.52, lower leverage | |
| Dividends | 0.0% yield; 2-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +347.6% vs SURG's -80.0% | |
| Efficiency (ROA) | 58.1% ROA vs SURG's -242.4%, ROIC 81.8% vs -229.7% |
SURG vs NVDA vs AMD vs LQDT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SURG vs NVDA vs AMD vs LQDT — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NVDA leads in 4 of 6 categories
SURG leads 0 • AMD leads 0 • LQDT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NVDA leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NVDA is the larger business by revenue, generating $215.9B annually — 4286.8x SURG's $50M. NVDA is the more profitable business, keeping 55.6% of every revenue dollar as net income compared to SURG's -83.4%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $50M | $215.9B | $37.5B | $480M |
| EBITDAEarnings before interest/tax | -$39M | $133.2B | $6.6B | $51M |
| Net IncomeAfter-tax profit | -$42M | $120.1B | $5.0B | $30M |
| Free Cash FlowCash after capex | -$26M | $96.7B | $8.6B | $78M |
| Gross MarginGross profit ÷ Revenue | -38.6% | +71.1% | +50.3% | +23.2% |
| Operating MarginEBIT ÷ Revenue | -78.8% | +60.4% | +11.7% | +8.4% |
| Net MarginNet income ÷ Revenue | -83.4% | +55.6% | +13.3% | +6.3% |
| FCF MarginFCF ÷ Revenue | -50.9% | +44.8% | +22.9% | +16.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.9% | +73.2% | +37.8% | +3.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +47.2% | +97.8% | +90.9% | +4.5% |
Valuation Metrics
Evenly matched — SURG and LQDT each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 41.6x trailing earnings, LQDT trades at a 76% valuation discount to AMD's 171.8x P/E. Adjusting for growth (PEG ratio), NVDA offers better value at 0.46x vs AMD's 33.25x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $11M | $5.23T | $742.1B | $1.1B |
| Enterprise ValueMkt cap + debt − cash | $4M | $5.23T | $741.0B | $962M |
| Trailing P/EPrice ÷ TTM EPS | -0.23x | 43.92x | 171.77x | 41.60x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 26.00x | 62.38x | 24.45x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.46x | 33.25x | — |
| EV / EBITDAEnterprise value multiple | — | 39.27x | 110.64x | 21.15x |
| Price / SalesMarket cap ÷ Revenue | 0.18x | 24.22x | 21.42x | 2.35x |
| Price / BookPrice ÷ Book value/share | 0.70x | 33.43x | 11.82x | 5.77x |
| Price / FCFMarket cap ÷ FCF | — | 54.10x | 110.19x | 19.04x |
Profitability & Efficiency
NVDA leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
NVDA delivers a 76.3% return on equity — every $100 of shareholder capital generates $76 in annual profit, vs $-10 for SURG. LQDT carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to SURG's 0.30x. On the Piotroski fundamental quality scale (0–9), AMD scores 8/9 vs SURG's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -10.1% | +76.3% | +8.1% | +14.2% |
| ROA (TTM)Return on assets | -2.4% | +58.1% | +6.5% | +8.0% |
| ROICReturn on invested capital | -2.3% | +81.8% | +4.7% | +60.8% |
| ROCEReturn on capital employed | -177.3% | +97.2% | +5.7% | +17.3% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 | 8 | 7 |
| Debt / EquityFinancial leverage | 0.30x | 0.07x | 0.07x | 0.07x |
| Net DebtTotal debt minus cash | -$7M | $807M | -$1.1B | -$160M |
| Cash & Equiv.Liquid assets | $12M | $10.6B | $5.5B | $175M |
| Total DebtShort + long-term debt | $5M | $11.4B | $4.5B | $14M |
| Interest CoverageEBIT ÷ Interest expense | -40.65x | 545.03x | 33.19x | — |
Total Returns (Dividends Reinvested)
NVDA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NVDA five years ago would be worth $150,908 today (with dividends reinvested), compared to $673 for SURG. Over the past 12 months, AMD leads with a +347.6% total return vs SURG's -80.0%. The 3-year compound annual growth rate (CAGR) favors NVDA at 94.7% vs SURG's -49.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -67.5% | +14.0% | +103.7% | +22.3% |
| 1-Year ReturnPast 12 months | -80.0% | +83.4% | +347.6% | +27.9% |
| 3-Year ReturnCumulative with dividends | -87.0% | +638.6% | +378.9% | +156.7% |
| 5-Year ReturnCumulative with dividends | -93.3% | +1409.1% | +499.0% | +45.9% |
| 10-Year ReturnCumulative with dividends | -99.1% | +24324.1% | +12371.0% | +507.2% |
| CAGR (3Y)Annualised 3-year return | -49.3% | +94.7% | +68.6% | +36.9% |
Risk & Volatility
Evenly matched — AMD and LQDT each lead in 1 of 2 comparable metrics.
Risk & Volatility
LQDT is the less volatile stock with a 0.82 beta — it tends to amplify market swings less than AMD's 2.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMD currently trades 99.8% from its 52-week high vs SURG's 16.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.27x | 1.74x | 2.52x | 0.82x |
| 52-Week HighHighest price in past year | $3.45 | $217.80 | $456.25 | $38.83 |
| 52-Week LowLowest price in past year | $0.46 | $115.21 | $101.56 | $21.67 |
| % of 52W HighCurrent price vs 52-week peak | +16.1% | +98.8% | +99.8% | +93.2% |
| RSI (14)Momentum oscillator 0–100 | 41.4 | 63.4 | 76.1 | 68.2 |
| Avg Volume (50D)Average daily shares traded | 366K | 160.0M | 36.8M | 160K |
Analyst Outlook
NVDA leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: NVDA as "Buy", AMD as "Buy", LQDT as "Buy". Consensus price targets imply 28.1% upside for NVDA (target: $276) vs -11.8% for AMD (target: $402).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $275.74 | $401.65 | $44.00 |
| # AnalystsCovering analysts | — | 79 | 70 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% | — | — |
| Dividend StreakConsecutive years of raises | — | 2 | 0 | 1 |
| Dividend / ShareAnnual DPS | — | $0.04 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +5.7% | +0.8% | +0.2% | +1.4% |
NVDA leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 2 categories are tied.
SURG vs NVDA vs AMD vs LQDT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SURG or NVDA or AMD or LQDT a better buy right now?
For growth investors, NVIDIA Corporation (NVDA) is the stronger pick with 65.
5% revenue growth year-over-year, versus -55. 6% for SurgePays, Inc. (SURG). Liquidity Services, Inc. (LQDT) offers the better valuation at 41. 6x trailing P/E (24. 5x forward), making it the more compelling value choice. Analysts rate NVIDIA Corporation (NVDA) a "Buy" — based on 79 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SURG or NVDA or AMD or LQDT?
On trailing P/E, Liquidity Services, Inc.
(LQDT) is the cheapest at 41. 6x versus Advanced Micro Devices, Inc. at 171. 8x. On forward P/E, Liquidity Services, Inc. is actually cheaper at 24. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NVIDIA Corporation wins at 0. 27x versus Advanced Micro Devices, Inc. 's 12. 08x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SURG or NVDA or AMD or LQDT?
Over the past 5 years, NVIDIA Corporation (NVDA) delivered a total return of +1409%, compared to -93.
3% for SurgePays, Inc. (SURG). Over 10 years, the gap is even starker: NVDA returned +243. 2% versus SURG's -99. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SURG or NVDA or AMD or LQDT?
By beta (market sensitivity over 5 years), Liquidity Services, Inc.
(LQDT) is the lower-risk stock at 0. 82β versus Advanced Micro Devices, Inc. 's 2. 52β — meaning AMD is approximately 208% more volatile than LQDT relative to the S&P 500. On balance sheet safety, Liquidity Services, Inc. (LQDT) carries a lower debt/equity ratio of 7% versus 30% for SurgePays, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SURG or NVDA or AMD or LQDT?
By revenue growth (latest reported year), NVIDIA Corporation (NVDA) is pulling ahead at 65.
5% versus -55. 6% for SurgePays, Inc. (SURG). On earnings-per-share growth, the picture is similar: Advanced Micro Devices, Inc. grew EPS 165. 0% year-over-year, compared to -273. 2% for SurgePays, Inc.. Over a 3-year CAGR, NVDA leads at 100. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SURG or NVDA or AMD or LQDT?
NVIDIA Corporation (NVDA) is the more profitable company, earning 55.
6% net margin versus -75. 1% for SurgePays, Inc. — meaning it keeps 55. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVDA leads at 60. 4% versus -68. 6% for SURG. At the gross margin level — before operating expenses — NVDA leads at 71. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SURG or NVDA or AMD or LQDT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NVIDIA Corporation (NVDA) is the more undervalued stock at a PEG of 0. 27x versus Advanced Micro Devices, Inc. 's 12. 08x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Liquidity Services, Inc. (LQDT) trades at 24. 5x forward P/E versus 62. 4x for Advanced Micro Devices, Inc. — 37. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NVDA: 28. 1% to $275. 74.
08Which pays a better dividend — SURG or NVDA or AMD or LQDT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is SURG or NVDA or AMD or LQDT better for a retirement portfolio?
For long-horizon retirement investors, Liquidity Services, Inc.
(LQDT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 82), +507. 2% 10Y return). Advanced Micro Devices, Inc. (AMD) carries a higher beta of 2. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LQDT: +507. 2%, AMD: +123. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SURG and NVDA and AMD and LQDT?
These companies operate in different sectors (SURG (Technology) and NVDA (Technology) and AMD (Technology) and LQDT (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SURG is a small-cap quality compounder stock; NVDA is a mega-cap high-growth stock; AMD is a large-cap high-growth stock; LQDT is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.